Skip to content
Recall Observatory FDA recall evidence

Device product

LDL-Cholesterol gen.2. The Boehringer Mannheim Direct LDL-Cholesterol test in intended for the quantitative determination of low-density lipoprotein Cholesterol (LDL-C) in serum and plasma.

Z-1927-2015

May 07, 2015

Class II

Product summary

Firm
Roche Diagnostics Operations, Inc.
Event
Event 71182
Status
Terminated
Classification
Class II
Quantity
6255
Official record key
device-enforcement:Z-1927-2015

Official wording

Reason: Possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine samples (Creatinine plus and Uric Acid applications only) or blood samples collected before sufficient time has lapsed after the administration of the drugs Acetaminophen and N-acetylcysteine.

Code information: Catalog numbers 04714423190; 04711220190; 05230438190; 05230446190.

Distribution pattern: US (nationwide) including PR.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine samples (Creatinine plus and Uric Acid applications only) or blood samples collected before sufficient time has lapsed after the administration of the drugs Acetaminophen and N-acetylcysteine.